Related Experiment Videos
A treatment strategy for Graves' orbitopathy.
Claudio Marcocci1, Aldo Pinchera, Michele Marinò
1Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy. c.marcocci@endoc.med.unipi.it
Nature Clinical Practice. Endocrinology & Metabolism
|April 25, 2007
Summary
This case study details a patient with nodular Graves' disease and severe Graves' orbitopathy. Treatment with glucocorticoids and orbital irradiation improved visual acuity but had limited effect on proptosis and eye motility.
Area of Science:
- Endocrinology and Ophthalmology
- Autoimmune thyroid disease management
- Graves' orbitopathy treatment outcomes
Background:
- A 59-year-old woman presented with thyrotoxic symptoms from nodular goiter, later diagnosed as nodular Graves' disease.
- Post-thyroidectomy, she developed severe Graves' orbitopathy (GO) with proptosis, diplopia, and reduced visual acuity, complicated by optic neuropathy.
Observation:
- Initial treatment with intravenous glucocorticoids provided transient symptom relief.
- Worsening eye motility and visual acuity reduction occurred after glucocorticoid withdrawal, necessitating further intervention.
Findings:
- A treatment regimen including high-dose intravenous glucocorticoids, orbital irradiation, and oral prednisone resulted in optimized visual acuity.
- Moderate improvement was noted in soft-tissue inflammation, but proptosis and eye motility showed only slight improvement.
Implications:
- This case highlights the complex management of severe Graves' orbitopathy, particularly when complicated by optic neuropathy.
- While medical therapy can improve visual acuity, surgical interventions like orbital decompression may be necessary for significant proptosis and motility issues.
Related Concept Videos
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...